Prostate Cancer Has a New Enemy: the Supercomputer

Prostate Cancer Has a New Enemy: the Supercomputer
Southern Methodist University (SMU) researchers say they have developed three drug-like compounds that could improve survival rates of prostate cancer patients. The compounds could be developed into medicine that targets P-gp, a protein responsible for resistance to chemotherapy. Scientists used SMU's Intel Xeon-driven ManeFrame high-performance computer to create a first-ever virtual model that could be tested with the compounds.